Cunha, Center for Neuroscience and Cell Biology of Coimbra and Faculty of Medication, University of Coimbra, Portugal, have assembled several international experts to explore the consequences of caffeine on the mind. The resulting assortment of original studies conveys multiple perspectives on topics which range from molecular targets of caffeine, neurophysiological adaptations and modifications, to the potential mechanisms underlying the behavioral and neuroprotective activities of caffeine in specific brain pathologies. Epidemiological research first exposed an inverse association between your chronic intake of caffeine and the incidence of Parkinson’s disease, regarding to Cunha and Mendon-a. This is paralleled by animal studies of Parkinson’s disease showing that caffeine prevented motor deficits along with neurodegeneration Later a few epidemiological studies showed that the consumption of moderate amounts of caffeine was inversely associated with the cognitive decline connected with aging as well as the incidence of Alzheimer’s disease.We anticipate working with Dr. Leavitt and the ADCS management group to build the ongoing organization through add-on acquisitions, greenfield growth, and by scaling the Ameriderm system through sales team optimization.’ Dr. Matt Leavitt, CEO and Founder of ADCS, said ‘We have been excited to be dealing with Audax Group. Their operational experience and successful background dealing with multi-site healthcare businesses will be instrumental once we continue steadily to build regional density and expand our provider supplying.’ Brentwood Capital Advisors, LLC suggested ADCS.